C-reactive protein comes of age. (Q36304216)

13 August 2017

1 reference

title

C-reactive protein comes of age. (English)

1 reference

13 August 2017

3

Paul M Ridker

1 reference

13 August 2017

Subodh Verma

1

1 reference

PubMed ID

16265340

13 August 2017

Paul E Szmitko

series ordinal

2

1 reference

13 August 2017

1 January 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

1

1 reference

13 August 2017

29-36; quiz 58

1 reference

Prevalence of conventional risk factors in patients with coronary heart disease.

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

New Markers of Inflammation and Endothelial Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Endothelial progenitor cells: new hope for a broken heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

C-reactive protein upregulates complement-inhibitory factors in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

High-density lipoproteins neutralize C-reactive protein proinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

C-reactive protein and prognosis after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Blood pressure, C-reactive protein, and risk of future cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Inflammatory markers and risk of developing type 2 diabetes in women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway:: an implication of CRP involvement in plaque destabilization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Human CRP Gene Polymorphism Influences CRP Levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0074

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0074

1 reference

13 August 2017

1 reference

PubMed ID

16265340